Today: March 23, 2018, 2:41 am

Merus to Present at the Jefferies London Healthcare Conference 2017-11-09 13:33:02

UTRECHT, The Netherlands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, CEO, will present at the Jefferies London Healthcare Conference on Thursday, November 16, 2017 at 4:40 PM GMT at the Waldorf Hilton in London, UK.

A live webcast of the Jefferies presentation will be available on the Investor page of the Company's website. An archived presentation will be available for 90 days.

About Merus N.V.
Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have several of the same features of conventional monoclonal antibodies, such as long half-life and low immunogenicity. Merus' lead bispecific antibody candidate, MCLA-128, is expected to begin a Phase 2 combination trial in the second half of 2017 in two metastatic breast cancer populations. MCLA-128 is also being evaluated in a Phase 1/2 clinical trial in Europe in gastric, ovarian, endometrial and non-small cell lung cancers. Merus' second bispecific antibody candidate, MCLA-117, is being developed in a Phase 1 clinical trial in patients with acute myeloid leukemia. The Company also has a pipeline of proprietary bispecific antibody candidates in preclinical development, including MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors, as well as MCLA-145 designed to bind to PD-L1 and a non-disclosed second immunomodulatory target, which is being developed in collaboration with Incyte Corporation.



Eliza Schleifstein
+1 973 361 1546

Kimberly Minarovich 
+1 646 368 8014

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Merus N.V. via Globenewswire

# 415 Words
Related Articles
More From The Author
Brookfield Asset Management Reports Third Quarter 2017 [..]
Brookfield Asset Management Reports Third Quarter 2017 Results   BROOKFIELD, NEWS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Brookfield Asset [..]
RedHill Biopharma Announces Last Patient Enrolled in [..]
Top-line results are expected to be announced in mid-2018  The Phase III study evaluating RHB-104 for Crohn's disease (MAP [..]
Chiara Padovani, from Studio Legale Padovani, is [..]
At the London Stock Exchange on Friday, 20 October 2017, Chiara Padovani received the prestigious Le Fonti Awards as Lawyer [..]
VistaJet Customers Grow by 50% in the [..]
The leader in global business aviation increases its offering to continue positive momentum in the region New Program hours doubled [..]
Crown Bioscience Inc. Announcing the 2017 Board [..]
Dr. Guoliang Yu re-elected as the Chairman TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary [..]
More From Business
RCBC Bankard launches new Platinum card with [..]
Manila, Philippines and Tokyo, Japan, Mar 22, 2018 - (ACN Newswire) - JCB International Co., Ltd. (JCBI), the international operations [..]
Project Laneways Offers Change Management Courses in [..]
Project Laneways has announced it will be conducting change management courses in Canberra in May. The Change Management Foundation [..]
Jaguar Leaps Onto The SUV Bandwagon With [..]
When it came to jumping on the SUV bandwagon, it was inevitable that Jaguar would make the leap; after all, [..]
Bright Light Stocks Independent Control Systems for [..]
Through their website Bright Light provides a range of independent control systems that will provide both hardwired and wireless [..]
Easy, Convenient and Time-saving: Steam Cleaning Without [..]
Kärcher Steam Cleaners give you the experience of cleaning chemical-free, killing 99.99% of common household bacteria, santitise [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.